Latest News

All Articles

Filter by:
Topic
Woman in chemo trial
HOPA Members

The Many Layers of BIPOC Underrepresentation in Cancer Clinical Trials

November 06, 2024

HOPA member Veronica B. Ajewole, PharmD, BCOP, brings her perspective on how to increase participation of Black, Indigenous, and People of Color (BIPOC) patients in cancer clinical trials.

Advocacy

HOPA and CMRignite Launch "Time to Talk Diversity in Clinical Trials" Campaign

November 04, 2024

HOPA and CMRignite have collaborated on "Time to Talk Diversity in Clinical Trials," a campaign to address the critical need for increased diversity in cancer clinical research and ensure that all patient populations are adequately represented.

Image of stem cell treatment
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Axatilimab-csfr

October 14, 2024

Sydney Hunt, PharmD, PGY-1 Pharmacist Resident, and Lindsay Orton, PharmD, BCOP, Stem Cell Transplant and Cellular Therapy Clinical Pharmacist, both from Vanderbilt University Medical Center, Nashville, TN, write about axatilimab-csfr (Niktimvo).

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Afamitresgene autoleucel

October 09, 2024

Emili Anderson, PharmD, PGY1 Acute Care Resident, and Roger Ngo, PharmD Candidate, both from UNC Medical Center, Chapel Hill, NC, write about afamitresgene autoleucel (afami-cel).

digital medical illustration of lung cancer in a person's chest
Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Tarlatamab-dlle

September 26, 2024

SeongEun Emily Park, PharmD PGY2-Hematology/Oncology Pharmacy Resident Emory University Hospital Midtown/Winship Cancer Institute writes about tarlatamab-dlle.

red blood cells under a microscope with signs of cancer
Tools and Resources Drug Updates

Pharmacist's Application to Practice: imetelstat

September 24, 2024

Brian Lam, PharmD, PGY2 Oncology Pharmacy Resident at University of North Carolina, Chapel Hill, NC writes about imetelstat

Late Breaking News

Clinical Oncology Pharmacy Technician: Impact of a New Role on Pharmacy and Patient Metrics at a Large Academic Cancer Center

September 20, 2024

A recently published article details the impact of having an inpatient clinical oncology pharmacy technician program.

Visual of data being collected
Late Breaking News

Oncology Pharmacy Staffing Survey Across Practice Settings in the United States

September 19, 2024

The results of a recently published pharmacy staffing model survey has brought new insights into oncology pharmacy operations across the country.

Digital medical illustration of a bladder
Tools and Resources Drug Updates

Pharmacist's Application
to Practice: Nogapendekin
alfa inbakicept-pmln

August 27, 2024

Devan Parker, PharmD, PGY2 Oncology Pharmacy Resident and Juliana Leedy, PharmD, MS, Clinical Oncology Pharmacist, The University of Alabama at Birmingham (UAB) Hospital, Birmingham, Alabama writes about nogapendekin alfa inbakicept-pmln.

LED sign that reads CAR T Cells
HOPA News Late Breaking News

Late-Breaking HOPA News: CAR-T Approval Updates

July 22, 2024

CAR-T approval updates show the treatment moving up the rung in Multiple Myeloma and breaking ground in Chronic Lymphocytic Leukemia

Early-Stage Non-small Cell Lung Cancer
Late Breaking News

Late-Breaking HOPA News: Adjuvant Alectinib in Early-Stage Non-small Cell Lung Cancer (NSCLC)

June 12, 2024

In April 2024, the FDA approved alectinib (Alecensa®) in patients with early-stage ALK-positive non-small cell lung cancer (NSCLC) based on the ALINA trial.

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Tislelizumab-jsgr

May 21, 2024

Kristine Pisikian, PharmD, PGY-1 Pharmacist Resident and Caroline Quinn, PharmD, BCOP, Specialty Clinical Program Director at Prime Therapeutics write about Tislelizumab-jsgr.